B. Cooper, M.D.
of Medicine and Physiology
Medical Director, Chronic Obstructive Pulmonary Disease Program
Medical Director, Clinical Exercise Physiology Laboratory
Director, Exercise Physiology Research Laboratory
Division of Pulmonary and Critical
David Geffen School of Medicine
37-131 Center for Health Sciences
10833 Le Conte Avenue
Los Angeles, CA 90095-1690
Specialty Consultation: 310-825-9711
General Internal Medicine: 310-206-6232
Chronic Obstructive Pulmonary: 310-206-7858
Pulmonary and Critical Care Medicine:
Exercise Physiology Laboratory:
Emergency: 310-825-6301 (UCLA page
<<back to faculty
B.Sc., University of London, England
M.B., B.S., University of London, England
M.D., University of London/St. Thomas’
M.D., Educational Commission for Foreign Medical
Fellowship, Pulmonary and Critical Care Medicine,
Trent Regional Health Authority, England
Fellowship, Pulmonary Disease, St. Thomas’
Resident Assistant Physician, Internal Medicine,
St. Thomas’ Hospital, London, England
Residency, Internal Medicine, St. Thomas’
Hospital, London, England
Internship, Internal Medicine, St. Thomas’
Hospital, London, England
Honors and Awards:
2010 Golden Apple Teaching Award (chosen by the medical school graduating class of 2010)
2009 Sherman Mellinkoff Faculty Award for dedication to the art of medicine and to the finest in doctor-patient relationships
2009 Award for Excellence in Education for outstanding dedication, innovation, and sustained excellence in education
1997 Fellowship of the AmericanCollege of Chest Physicians
1996 Fellowship of the AmericanCollege of Sports Medicine
1994 Fellowship of the RoyalCollege of Physicians of the United Kingdom
1987 Travelling Fellowship of the RoyalCollege of Physicians of Edinburgh
1987 Scadding Morriston-Davies Joint Fellowship in Respiratory Medicine
1987 Fulbright Scholarship
>>back to top
obstructive pulmonary disease
diseases which affect the respiratory system
testing and interpretation
physiology and fitness
physiology and pathophysiology
obstructive pulmonary disease
- Critical Care Medicine, Royal College of Physicians, UK 1987
- Pulmonary Disease, Royal College of Physicians, UK 1987
- Internal Medicine, Royal College of Physicians, UK 1980
Care Medicine, Royal College of Physicians,
Disease, Royal College of Physicians, UK
Medicine, Royal College of Physicians, UK
Cooper CB. Methods of rehabilitation in chronic obstructive pulmonary disease. MD Thesis, University of London, 1990.
Cooper CB, Storer TW. Exercise testing and interpretation. A practical approach. Cambridge University Press, Cambridge, England, 2001. ISBN: 0521648424.
Cooper CB. Determining the role of exercise in chronic pulmonary diseases. Med Sci Sports Exerc 1995; 27: 147-157.
Riley MS, Wasserman K, Fu P, Cooper CB. Muscle substrate utilization determined from alveolar gas exchange in trained cyclists. Eur J Appl Physiol 1996; 72: 341-348.
Casaburi R, Burns MR, Porszasz J, Carithers ER, Chang RSY, Cooper CB. Physiologic benefits of exercise training in rehabilitation of severe COPD patients. Am J Respir Crit Care Med 1997; 155: 1541-1551.
Markovitz GH, Cooper CB. Exercise in interstitial lung disease. Current Opinion in Pulmonary Medicine 1998; 4: 272-280.
Cooper, CB. Exercise in chronic pulmonary disease: Limitations and Rehabilitation. Med Sci Sports Exerc 2001; 33(7 Suppl): S643-646.
Cooper, CB. Exercise in chronic pulmonary disease: Aerobic exercise prescription. Med Sci Sports Exerc 2001; 33(7 Suppl): S671-679.
Riley M, Cooper CB. Ventilatory and gas exchange responses during heavy constant work-rate exercise. Med Sci Sports Exerc 2002: 34(1); 98-104
Nield M, Arora A, Dracup K, Simmons M, Soo Hoo G, Cooper CB. Comparison of breathing patterns during exercise in patients with obstructive and restrictive ventilatory abnormalities. J Rehab Res Development 2003; 40(5): 407-414.
Malek MH, Fonkalsrud EW, Cooper CB. Ventilatory and cardiovascular responses to exercise in patients with pectus excavatum. Chest 2003; 124: 870-882
Tashkin DP, Cooper CB. The role of bronchodilators in the mangement of stable chronic obstructive pulmonary disease. Chest 2004; 125: 249-259
Markovitz GH, Storer TW, Sayre JW, Cooper CB. Reproducibility of oxygen uptake kinetics. Brit J Sports Med 2004; 38: 553-560.
Cooper CB. Exercise testing does not have to be complicated. Chronic Respir Dis 2006; 3: 1-2.
Kesten S, Casaburi R, Kukafka D, Cooper CB. Improvement in self-reported exercise participation with the combination of tiotropium and rehabilitative exercise training in COPD patients. Int J COPD 2008; 3: 127-136.
Weigt SS, Abrazado M, Kleerup EC, Tashkin DP, Cooper CB. Time course and degree of hyperinflation with metronome-paced tachypnea in COPD patients. J COPD 2008; 5(5): 298-304.
Cooper CB. Desensitization to dyspnea in COPD with specificity for exercise training mode. Int J COPD 2008; 4: 33-43.
Cooper CB, Dransfield M. The COPD Patient in Primary Care—Part 4: Understanding the Clinical Manifestations of a Progressive Disease. Am J Med 2008; 121: S33-45.
Cooper CB, Celli B. Venous admixture in COPD: Pathophysiology and therapeutic approaches. J COPD 2008; 5: 376-381.
Cooper CB. Chronic obstructive pulmonary disease. In: American College of Sports Medicine. Exercise management for persons with chronic diseases and disabilities, 3rd ed. Champaign: Human Kinetics, 2008.
Cooper CB, Boscardin WJ, Colthurst JR, Kleerup EC. Treatment of mild persistent asthma by cutaneous electronic stimulation. Eur Respir J 2009; 34: 515-517.
Cooper CB. Airflow obstruction and exercise. Respir Med 2009; 103(3): 325-334.
Cooper CB. Respiratory applications of telemedicine. Thorax 2009; 64(3): 189-191.
Markovitz G, Colthurst J, Storer TW, Cooper CB. Effective inspired oxygen concentration measured by transtracheal and oral gas analysis. Respir Care 2010; 55(4): 453-459.
Chen S, Li Z, Krochmal R, Abrazado M, Kim W, Cooper CB. Effect of Cordyceps sinensis on exercise performance in healthy older subjects: a placebo controlled trial. J Alt Comp Med 2010; 16(5): 585-590.
Faul JL, Galindo J, Pasados R, Elizondo-Riojas G, Martinez A, Cooper CB. An arteriovenous fistula improves exercise capacity in COPD. Chest 2010; 138(1): 52-58.
Saleh R, Finn P, Fenchel M, Moghadam A, Abrazado M, Ton A, Habibi R, Fonkalsrud EW, Cooper CB. Cardiovascular magnetic resonance in patients with pectus excavatum campared with normal controls. J Cardiovascular Magnetic Resonance 2010 (in press).
Cooper CB, Storer TW. Pulmonary disease. In: ACSM Resource Manual for Guidelines for Exercise Testing and Prescription, 6th Ed. Lippincott, Williams & Wilkins, Baltimore, MD, 2010.
Cooper CB. Chronic obstructive pulmonary disease. In: Oxford desk manual. Oxford Medicine Publishing Group, 2010.
Markovitz GH, Cooper CB. Rehabilitation in non-COPD: Mechanisms of exercise limitation and pulmonary rehabilitation for patients with pulmonary fibrosis/restrictive lung disease. Chronic Respir Dis 2010; 7(1): 47-60.
Decramer M, Cooper CB. Treatment of COPD: The sooner the better. Thorax 2010; 65: 837-841.
>>back to top
of California at Los Angeles